Dublin, April 06, 2023 (GLOBE NEWSWIRE) -- The "Global Markets and Technologies for Cell and Tissue Analysis" report has been added to ResearchAndMarkets.com's offering.
The global market for cell and tissue analysis was estimated to be $16.7 billion in 2021 and is expected to increase to $28.9 billion in 2027, growing at a CAGR of 9.6% during the forecast period.
In this report the cell and tissue analysis market is segmented based on technology type, end user and region. Major players in the market are Thermo Fisher Scientific, Danaher, Becton, Dickinson & Co., Illumina, and Agilent Technologies. Technology types covered are biospecimen technology, cell separation, and cell and tissue characterization. Based on type, the cell and tissue characterization segment has the highest share. Each type is further categorized into subtypes.
Cell and tissue analysis products are playing pivotal roles in biomedical research. In the expanding field of biomedical research and development researchers and scientists employ a variety of cell and tissue analysis products. These products play important roles in the diagnosis of various forms of cancer and other diseases and also assume crucial roles when it comes to understanding diverse cellular activities.
With the rise of chronic and infectious diseases, there is an urgent need for efficient diagnostics and better healthcare conditions to treat diseases. Along with the recent intensification of research in academia and the biomedical industry, demand is increasing significantly for advanced technology for drug development and screening.
Personalized drug treatment is becoming a reality. In response to the rise in the incidence of a number of diseases and an ageing population, the drug discovery industry is developing new and more efficacious drugs based on specific biomarker signatures and hence cell and tissue analysis technologies will also help in personalized drug development.
Apart from this the increasing demand for single-cell analysis and the extensive research ongoing in this area will further contribute to the market. Other drivers contributing to the market include advances in technologies and product launches, increasing prevalence of chronic diseases, an ageing population, and rising investments and funding. However, the market is facing some challenges such as the high cost of instruments, lack of skilled labor and stringent regulations.
North America has the highest share of the market by region, followed by Europe. Extensive R&D activities take place in the region, there are major players present, there is plentiful funding, and there is an increasing prevalence of chronic diseases. All these factors will contribute to growth in the market
Report Includes
- A detailed overview and an up-to-date analysis of the global market for cell and tissue analysis (CTA) products and technologies
- Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Discussion of the industry growth driving factors and restraints that will shape the market for CTA products as the basis for projecting demand over the next few years (2022-2027)
- Estimation of the actual market size and revenue forecast for global cell and tissue analysis products market in USD millions, and corresponding market share analysis by type, application, end-user, and region
- Review of the commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years
- Identification of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players
- Insight into the recent industry structure, government regulations and policies, development issues, and the vendor landscape
- Information about patents and patent applications for cell and tissue analysis products and technologies by each major category
- Market share analysis of the key market participants, along with their research priorities, product portfolios, and competitive landscape
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 151 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value (USD) in 2022 | $18.2 Billion |
| Forecasted Market Value (USD) by 2027 | $28.9 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
3.1 Introduction
3.1.1 History
3.1.2 Cells
3.1.3 Animal Tissue
3.2 Classification of Techniques Used in Cell and Tissue Analysis
3.3 Biospecimen Techniques
3.3.1 Microarray
3.3.2 Tissue Microarrays
3.3.3 Cellular Microarray
3.3.4 Dna Microarray or Dna Chip
3.3.5 Protein Microarray or Peptide Chip
3.4 Cell-Separation Techniques
3.4.1 Mechanical and Physical Dissociation
3.4.2 Based on Adherence
3.4.3 Based on Size and Density
3.4.4 Based on Affinity
3.4.5 Lab-On-Chip Techniques
3.5 Cell and Tissue Characterization
3.5.1 Cell-Based Assays
3.5.2 Histology and Immunohistochemistry
3.5.3 Flow Cytometry
3.5.4 Genotyping and Expression Analysis
3.5.5 Western Analysis
3.5.6 Components of Cell-Based Assays
Chapter 4 Market Dynamics
4.1 Factors Affecting the Market
4.1.1 Market Drivers
4.1.2 Challenges for the Market for Cell and Tissue Analysis
4.1.3 Impact of the Covid-19 Pandemic
Chapter 5 Emerging Technologies
Chapter 6 Market Breakdown by Technology
6.1 Cell and Tissue Analysis Technologies
6.1.1 Biospecimen Technology
6.1.2 Cell Separation Technology
6.1.3 Cell and Tissue Characterization
Chapter 7 Market Breakdown by End-user
7.1 End-users
7.1.1 Biopharmaceutical Companies
7.1.2 Academic and Research Institutes
7.1.3 Healthcare and Clinical
Chapter 8 Market Breakdown by Region
8.1 North America
8.2 Europe
8.3 Emerging Markets
Chapter 9 Regulatory Aspects
9.1 New Approvals of Cell and Tissue Analysis Products
9.2 Recalls and Safety Alerts
Chapter 10 Patent Analysis
10.1 Patent Activity on Cell and Tissue Analysis
10.1.1 Patent Review by Year
10.1.2 Patent Review by Country
10.1.3 Patent Review by Company, University and Institute
Chapter 11 Competitive Landscape
11.1 Mergers and Acquisitions
11.2 Competitive Analysis
11.2.1 Biospecimen Technology
11.2.2 Cell Separation Technology
11.2.3 Cell and Tissue Characterization Technology
Chapter 12 Company Profiles
- Abcam plc
- Abnova Corp.
- Agilent Technologies Inc.
- Arrayit Corp.
- Becton, Dickinson & Co.
- Bio-Rad Laboratories Inc.
- Bio-Techne Corp.
- Carl Zeiss
- Cell Signaling Technology Inc.
- Danaher Corp.
- Fujifilm Cellular Dynamics Inc. (Fcdi)
- Ge Healthcare
- F. Hoffmann-La Roche AG
- Illumina Inc.
- Luminex Corp.
- Merck Kgaa
- Miltenyi Biotec
- Perkinelmer Inc.
- Sartorius AG
- Stemcell Technologies
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Worthington Biochemical Corp.
Companies Mentioned
- Abcam plc
- Abnova Corp.
- Agilent Technologies Inc.
- Arrayit Corp.
- Becton, Dickinson & Co.
- Bio-Rad Laboratories Inc.
- Bio-Techne Corp.
- Carl Zeiss
- Cell Signaling Technology Inc.
- Danaher Corp.
- F. Hoffmann-La Roche AG
- Fujifilm Cellular Dynamics Inc. (Fcdi)
- Ge Healthcare
- Illumina Inc.
- Luminex Corp.
- Merck Kgaa
- Miltenyi Biotec
- Perkinelmer Inc.
- Sartorius AG
- Stemcell Technologies
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Worthington Biochemical Corp.
For more information about this report visit https://www.researchandmarkets.com/r/vzu9bg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
